NASDAQ:BSGM BioSig Technologies (BSGM) Stock Forecast, Price & News $0.50 -0.03 (-5.61%) (As of 09/27/2023 ET) Add Compare Share Share Today's Range$0.50▼$0.5650-Day Range$0.41▼$1.3952-Week Range$0.25▼$1.65Volume110,562 shsAverage Volume490,652 shsMarket Capitalization$37.79 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media BioSig Technologies MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside594.0% Upside$3.50 Price TargetShort InterestHealthy3.32% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.29Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.42) to ($0.24) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.11 out of 5 starsMedical Sector523rd out of 976 stocksElectromedical Equipment Industry12th out of 22 stocks 3.5 Analyst's Opinion Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.50, BioSig Technologies has a forecasted upside of 594.0% from its current price of $0.50.Amount of Analyst CoverageBioSig Technologies has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.32% of the outstanding shares of BioSig Technologies have been sold short.Short Interest Ratio / Days to CoverBioSig Technologies has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BioSig Technologies has recently decreased by 2.73%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BSGM. Previous Next 2.4 News and Social Media Coverage News SentimentBioSig Technologies has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for BioSig Technologies this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for BSGM on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat Follows8 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders11.88% of the stock of BioSig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.16% of the stock of BioSig Technologies is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for BioSig Technologies are expected to grow in the coming year, from ($0.42) to ($0.24) per share.Price to Book Value per Share RatioBioSig Technologies has a P/B Ratio of 50.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About BioSig Technologies (NASDAQ:BSGM) StockBioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More BSGM Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSGM Stock News HeadlinesSeptember 19, 2023 | americanbankingnews.comComparing Integer (NYSE:ITGR) & BioSig Technologies (NASDAQ:BSGM)September 6, 2023 | benzinga.comBioSig – Medical Device Maker Is Revolutionizing How Arrhythmias Are TreatedSeptember 28, 2023 | UNKNOWN (Ad)The Bio-Tech Stock That Needs Your Attention!There a Few Opportunities Like This Stock! Sign Up Today And Get Our NExt Bio-Tech Alert!August 25, 2023 | finance.yahoo.comBioSig (BSGM) Grows in Arrhythmia Care With Subscription ModelAugust 24, 2023 | finance.yahoo.comBioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for HospitalsAugust 16, 2023 | finance.yahoo.comBioSig Technologies Second Quarter 2023 Earnings: US$0.16 loss per share (vs US$0.15 loss in 2Q 2022)July 25, 2023 | finance.yahoo.comBioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence ApplicationsJuly 21, 2023 | finance.yahoo.comNVIDIA Inception Chooses BioSig AI For Innovation In Healthcare AI, An Industry That Is Projected To Reach $272.9 Billion By 2030September 28, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.July 20, 2023 | theglobeandmail.comHealthcare Shares Bid Up Following Major Premarket AnnouncementJuly 20, 2023 | markets.businessinsider.comWhy Is BioSig Technologies (BSGM) Stock Up 19% Today?July 20, 2023 | finance.yahoo.comBioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for HospitalsJune 29, 2023 | finance.yahoo.comBioSig Joins Webull Corporate ConnectJune 27, 2023 | finance.yahoo.comBioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for HealthcareMay 24, 2023 | benzinga.comNew Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation MarketMay 19, 2023 | finance.yahoo.comNew Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating ArrhythmiasMay 16, 2023 | investing.comBiosig Tech (BSGM) Earnings Dates & ReportsMarch 27, 2023 | finance.yahoo.comBioSig Announces New Advisory Board Member Edwin WangMarch 24, 2023 | finance.yahoo.comBioSig Announces New Advisory Board Member Lorraine SpurgeMarch 13, 2023 | finance.yahoo.comBioSig Confirms No Exposure to Silicon Valley BankFebruary 22, 2023 | finance.yahoo.comBioSig Regains Compliance With All Nasdaq Listing StandardsFebruary 22, 2023 | finance.yahoo.comBioSig Regains Compliance With All Nasdaq Listing StandardsFebruary 17, 2023 | finance.yahoo.comBioSig Awarded US Patent Claims for its Universal Notch Filter TechnologyFebruary 7, 2023 | msn.comBioSig names Steve Buhaly CFO replacing ChaussyFebruary 7, 2023 | marketwatch.comBioSig Names Buhaly as Finance Chief as Chaussy to Retire >BSGMFebruary 7, 2023 | finance.yahoo.comBioSig Appoints Former Qorvo CFO as Successor to Steve ChaussyJanuary 19, 2023 | finance.yahoo.comBioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing DevelopmentsSee More Headlines Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address BSGM Company Calendar Last Earnings3/31/2022Today9/28/2023Next Earnings (Estimated)10/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees47Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.50 High Stock Price Forecast$5.00 Low Stock Price Forecast$2.00 Forecasted Upside/Downside+594.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-27,050,000.00 Net Margins-9,336.04% Pretax Margin-11,633.82% Return on Equity-2,915.50% Return on Assets-693.01% Debt Debt-to-Equity RatioN/A Current Ratio0.60 Quick Ratio0.54 Sales & Book Value Annual Sales$290,000.00 Price / Sales130.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book50.43Miscellaneous Outstanding Shares74,930,000Free Float66,026,000Market Cap$37.79 million OptionableNot Optionable Beta1.37 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Kenneth L. Londoner M.B.A. (Age 55)MBA, Founder, CEO & Exec. Chairman Comp: $1.17MMr. John Sieckhaus (Age 55)Chief Operating Officer Comp: $282.52kMr. Michael Graydon Fleming Jr. (Age 49)Chief Commercial Officer Comp: $400kMr. Steven J. Buhaly (Age 66)Chief Financial Officer Dr. Budimir S. Drakulic Ph.D. (Age 73)Chief Scientist Mr. Andrew Gornell BallouVP of Investor RelationsMs. Brenda CastrodadVP of HRMore ExecutivesKey CompetitorsPrecision OpticsNASDAQ:POCIelectroCoreNASDAQ:ECORVivani MedicalNASDAQ:VANINeurAxisNASDAQ:NRXSMovanoNASDAQ:MOVEView All CompetitorsInsiders & InstitutionsRoyal Bank of CanadaBought 17,700 shares on 8/15/2023Ownership: 0.035%Citadel Advisors LLCSold 100 shares on 8/15/2023Ownership: 0.000%BlackRock Inc.Bought 144,300 shares on 8/11/2023Ownership: 0.843%Geode Capital Management LLCBought 227,054 shares on 8/11/2023Ownership: 0.803%Northern Trust CorpBought 21,995 shares on 8/11/2023Ownership: 0.157%View All Insider TransactionsView All Institutional Transactions BSGM Stock - Frequently Asked Questions Should I buy or sell BioSig Technologies stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BSGM shares. View BSGM analyst ratings or view top-rated stocks. What is BioSig Technologies' stock price forecast for 2023? 2 Wall Street research analysts have issued 1-year price targets for BioSig Technologies' stock. Their BSGM share price forecasts range from $2.00 to $5.00. On average, they predict the company's share price to reach $3.50 in the next twelve months. This suggests a possible upside of 594.0% from the stock's current price. View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts. How have BSGM shares performed in 2023? BioSig Technologies' stock was trading at $0.42 at the beginning of 2023. Since then, BSGM stock has increased by 20.1% and is now trading at $0.5043. View the best growth stocks for 2023 here. When is BioSig Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 2nd 2023. View our BSGM earnings forecast. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) posted its earnings results on Thursday, March, 31st. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 9,336.04% and a negative trailing twelve-month return on equity of 2,915.50%. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU). What is BioSig Technologies' stock symbol? BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM." Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Advisor Resource Council (1.28%), BlackRock Inc. (0.84%), Geode Capital Management LLC (0.80%), Northern Trust Corp (0.16%), PFG Investments LLC (0.11%) and Sequoia Financial Advisors LLC (0.10%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is BioSig Technologies' stock price today? One share of BSGM stock can currently be purchased for approximately $0.50. How much money does BioSig Technologies make? BioSig Technologies (NASDAQ:BSGM) has a market capitalization of $37.79 million and generates $290,000.00 in revenue each year. How can I contact BioSig Technologies? BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The official website for the company is www.biosig.com. The company can be reached via phone at (230) 409-5444 or via email at info@biosigtech.com. This page (NASDAQ:BSGM) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.